Abstract
Donor mononuclear cell (MNC) infusions provide a very potent and effective anti-leukemic therapy. For patient's with CML who relapse after allogeneic BMT, the administration of donor MNC can result in a direct GVL effect and re-establish sustained remissions, even when assessed by very sensitive PCR-based techniques. The GVL reaction appears to be most prominent in patients with chronic phase CML. It is less apparent for patients with more advanced stages of CML or for patients with relapsed acute leukemia and myelodysplasia, although only small numbers of these patients have been treated. While the majority of patients tolerate this therapy very well, treatment related morbidity and mortality is still quite significant, and efforts to limit the severity of GVHD, and to recognize and treat marrow aplasia early may be useful. Longer follow-up of patients who have achieved complete remission will be required to determine if this therapy will have an impact on long term disease free survival, but at the current time, it would seem to be a very acceptable alternative to a second BMT.
References
May 10, 1979·The New England Journal of Medicine·P L WeidenR Storb
Sep 9, 1978·Lancet·L F OdomF B Johnson
Jan 1, 1992·Cancer Investigation·S SlavinE Naparstek
Aug 1, 1990·Scandinavian Journal of Immunology·C Cray, R B Levy
Apr 1, 1991·Annals of Internal Medicine·M TalpazJ U Gutterman
Feb 1, 1990·The New England Journal of Medicine·K E AndersonR B Stead
Jul 1, 1990·Transplantation·C S HiganoJ W Singer
Mar 30, 1989·The New England Journal of Medicine·K M SullivanJ Hansen
Jul 25, 1987·Lancet·D MaraninchiN Ifrah
Jun 1, 1988·Annals of Internal Medicine·J M GoldmanP B McGlave
Jun 1, 1988·British Journal of Haematology·J F ApperleyD Wardle
Jul 7, 1984·Lancet·R P Gale, R E Champlin
Sep 9, 1993·The New England Journal of Medicine·S GiraltA Cork
Nov 1, 1993·Transplantation·B HertensteinR Arnold
Jan 13, 1994·The New England Journal of Medicine·D L PorterJ H Antin
Jan 1, 1994·Transplantation·S D NimerM Selch
Feb 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P RadichJ A Hansen
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B M BärT De Witte
Aug 1, 1994·Sports Medicine·D D PascoeB S McCluskey
Jul 1, 1957·British Journal of Haematology·D W BARNES, J F LOUTIT
Citations
Dec 1, 1995·Medical Oncology·T D MialeS Ahmed
Apr 2, 1998·Hematology/oncology Clinics of North America·D L Porter, J H Antin
Jan 20, 1999·The British Journal of Dermatology·M Jones-CaballeroA García-Díez
Jul 20, 2010·Immunotherapy·Joshua Brody, Ronald Levy
Nov 15, 2011·Journal of Strength and Conditioning Research·Ana L Dias QuiterioLuís B Sardinha
Sep 26, 2006·Best Practice & Research. Clinical Haematology·David L Porter, Joseph H Antin
Jun 1, 1997·Immunological Reviews·W J Murphy, D L Longo
Jul 16, 1999·Pediatric Pulmonology·H LeneveuG Dutau
Aug 1, 1997·Disease-a-month : DM·P Jacobs